Cargando…
Proton pump inhibitors versus H2 antagonists for prevention of COVID-19 complications
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Southern Society for Clinical Investigation. Published by Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883784/ http://dx.doi.org/10.1016/S0002-9629(23)00651-1 |
_version_ | 1784879580631269376 |
---|---|
author | Kishore, E Singh, V Dihowm, F |
author_facet | Kishore, E Singh, V Dihowm, F |
author_sort | Kishore, E |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9883784 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Southern Society for Clinical Investigation. Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-98837842023-01-30 Proton pump inhibitors versus H2 antagonists for prevention of COVID-19 complications Kishore, E Singh, V Dihowm, F Am J Med Sci Concurrent Session: Gastroenterology, Nutrition & Dietary Supplements II Southern Society for Clinical Investigation. Published by Elsevier Inc. 2023-02 2023-01-27 /pmc/articles/PMC9883784/ http://dx.doi.org/10.1016/S0002-9629(23)00651-1 Text en Copyright © 2023 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Concurrent Session: Gastroenterology, Nutrition & Dietary Supplements II Kishore, E Singh, V Dihowm, F Proton pump inhibitors versus H2 antagonists for prevention of COVID-19 complications |
title | Proton pump inhibitors versus H2 antagonists for prevention of COVID-19 complications |
title_full | Proton pump inhibitors versus H2 antagonists for prevention of COVID-19 complications |
title_fullStr | Proton pump inhibitors versus H2 antagonists for prevention of COVID-19 complications |
title_full_unstemmed | Proton pump inhibitors versus H2 antagonists for prevention of COVID-19 complications |
title_short | Proton pump inhibitors versus H2 antagonists for prevention of COVID-19 complications |
title_sort | proton pump inhibitors versus h2 antagonists for prevention of covid-19 complications |
topic | Concurrent Session: Gastroenterology, Nutrition & Dietary Supplements II |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883784/ http://dx.doi.org/10.1016/S0002-9629(23)00651-1 |
work_keys_str_mv | AT kishoree protonpumpinhibitorsversush2antagonistsforpreventionofcovid19complications AT singhv protonpumpinhibitorsversush2antagonistsforpreventionofcovid19complications AT dihowmf protonpumpinhibitorsversush2antagonistsforpreventionofcovid19complications |